MTOR and nonpapillary renal cell carcinoma: The VHL-HIF-METTL3/14 pathway may be involved in the regulation of m6A in ccRCC, and the PI3K-mTOR and p53 signaling pathways may be downstream targets of m6A in ccRCC [134].